Authors
Latest Article
VISUMAX 800 - Why speed matters
Matt Hoffman is the editorial director for Ophthalmology Times, Modern Retina, and Ophthalmology Times Europe. He has covered medical news for MJH Life Sciences, Eye Care Network’s parent company, since 2017.
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
2
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
3
FLORetina 2025: New horizons in research and risk management for ROP
4
FLORetina 2025: Navigating antithrombotic therapy in wet AMD
5

